Related Experiment Video
Updated: Jun 18, 2025
Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Risk Prediction Models for Ischemic Cardiovascular Outcomes in Patients with Acute Coronary Syndrome
Qi Zhang1,2,3,4, Jie Gao1,2,3,4, Xiaoying Yin1,2,3,4
1Department of Emergency Medicine, Qilu Hospital of Shandong University, 250012 Jinan, Shandong, China.
Insights
Acute coronary syndrome (ACS) patients need risk assessment for better survival. Clinical risk scores help predict prognosis and guide effective, timely treatment to prevent adverse cardiovascular events.
Area of Science:
- Cardiology
- Clinical Risk Assessment
- Preventive Medicine
Background:
- Acute coronary syndrome (ACS) frequently leads to adverse cardiovascular events, even with early intervention.
- Patients with ACS often face a poor prognosis post-discharge, highlighting the need for improved long-term management strategies.
Purpose of the Study:
- To review existing risk scores for predicting mortality and ischemic events in ACS patients.
- To emphasize the importance of risk stratification in tailoring treatment plans for ACS survivors.
Main Methods:
- Literature review of clinical risk prediction models for ACS.
- Analysis of studies correlating risk scores with patient outcomes (mortality, ischemic events).
Main Results:
- Risk assessment models are crucial for identifying high-risk ACS patients.
- Clinical risk scores enable accurate prognosis evaluation and personalized treatment strategies.
Conclusions:
- Effective risk stratification using validated scores is essential for improving long-term survival in ACS patients.
- Timely and appropriate treatment, guided by risk assessment, can mitigate short- and long-term cardiovascular risks.
Abstract:
Acute coronary syndrome (ACS) has a high incidence of adverse cardiovascular events, even after early invasive treatment. Patients may still have a poor prognosis after discharge. The keys to the long-term survival of patients with ACS include effective treatment in a timely manner and identification of those patients who are at higher risk for long-term adverse events. Therefore, several nations have now devised a range of risk assessment models to provide data for accurately formulating treatment plans for patients with various risk levels following an ACS to prevent short and long-term cardiovascular events. The purpose of this article is to review the risk scores associated with mortality and ischemic events in patients with ACS. By using the clinical risk prediction score, we can accurately and effectively judge the prognosis of patients, so as to take a more reasonable treatment.
More Related Videos
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
Related Concept Videos
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...